—#93597

Product

Sex Hormone Binding Globulin (SHBG) Reagent for use on Access Immunoassay Systems, Part number(s): A48617 The Access SHBG assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of Sex Hormone Binding Globulin levels in human serum and plasma using the Access Immunoassay Systems.

FDA product code: CDZ — Radioimmunoassay, Testosterones And Dihydrotestosterone
Device class: Class 1
Medical specialty: Clinical Chemistry
510(k) numbers: K083867
Affected lot / code info: Lot Numbers:009046, 010202, 829586, 909837, 914557, 915628, 917613, 919184

Why it was recalled

The recall was initiated because the Instruction for Use (IFU) for Access SHBG does not specify the units of measure to be used when calculating the Free Androgen Index (FAI %). Access SHBG (nmol/L) values and Access Testosterone (ng/mL) values are reported in different default units. The testosterone value (when reported in ng/mL) requires conversion to nmol/L before the FAI % can be calculated.

Root cause (FDA determination)

Pending

Action the firm took

Beckman Coulter sent an Urgent Product Corrective Action (PCA) letter on the week of July 26, 2010 to the affected customers. The letter was dated July 30, 2010, and identified the product, the problem and provided the appropriate equation to recalculate the FAI% values. The customers were asked to share this information with their laboratory staff and retain the notification as part of their laboratory Quality System documentation. Customers were also asked to complete and return the enclosed response form within 10 days to confirm that they had received the important notification. The customers were instructed to contact Beckman Coulter Technical Support at 1-800-854-3633 in the United States, or contact their local Beckman Coulter Representative if they had any questions regarding the notification.

Recalling firm

Firm: Beckman Coulter Inc.
Address: 200 S Kraemer Blvd, Brea, California 92821-6208

Distribution

Distribution pattern: Worldwide Distribution - USA including AL, AR, CA, CO, FL, GA, IL, IN, LA, MA, MI, MN, MO, MS, NC, NE, NV, NY, OH, OK, OR, TN, TX, UT, VA, WA, AND WI and the country of Canada

Timeline

Recall initiated: 2010-07-26
Posted by FDA: 2010-11-22
Terminated: 2012-05-04
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #93597. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.